Pura Vida Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-495,100
Closed -$34.2M 54
2024
Q1
$34.2M Buy
+495,100
New +$31.3M 5.76% 5
2023
Q1
Sell
-275,000
Closed -$13.6M 114
2022
Q4
$13.6M Sell
275,000
-100,000
-27% -$4.09M 0.7% 35
2022
Q3
$12.2M Buy
375,000
+240,000
+178% +$9.89M 0.71% 43
2022
Q2
$5.32M Hold
135,000
0.31% 83
2022
Q1
$9.44M Buy
+135,000
New +$9.87M 0.31% 84
2020
Q4
Sell
-40,000
Closed -$4.08M 198
2020
Q3
$4.08M Buy
+40,000
New +$3.45M 0.21% 95
2016
Q4
Sell
-100,000
Closed -$1.86M 75
2016
Q3
$1.86M Buy
+100,000
New +$1.76M 0.56% 63

Other funds holding EXAS

Pura Vida Investments's EXAS Position: Q2 2024 in Review

Pura Vida Investments sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 481,910 shares — an estimated $33.3M sold.

Pura Vida Investments first reported a position in EXAS in Q4 2014 and held it in 4 quarters. The position peaked at $33.3M in Q1 2024. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Pura Vida Investments reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Pura Vida Investments sold 481,910 Exact Sciences shares in Q2 2024, an estimated $33.3M.
  • Pura Vida Investments first reported a position in Exact Sciences in Q4 2014 and held it in 4 quarters.
  • Pura Vida Investments's Exact Sciences position peaked at $33.3M in Q1 2024.
  • 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.